Scott critiques Palantir's approach to corporate governance, highlighting their questionable investments in SPACs using shareholder funds. He argues that this strategy creates a misleading perception of organic growth and risks significant fallout when these SPACs inevitably falter. The reliance on related party transactions raises concerns about the true health of Palantir's business model, especially as economic corrections loom.
